Advanced company searchLink opens in new window

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Company number 09686738

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
04 Jul 2022 SH10 Particulars of variation of rights attached to shares
23 Jun 2022 AP01 Appointment of David Min Chao as a director on 17 June 2022
15 Mar 2022 SH01 Statement of capital following an allotment of shares on 14 March 2022
  • GBP 35,469.22
10 Jan 2022 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021
07 Jan 2022 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021
07 Jan 2022 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
05 Jan 2022 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 29 January 2021
30 Nov 2021 TM01 Termination of appointment of Saurabh Saha as a director on 30 November 2021
30 Nov 2021 AD01 Registered office address changed from C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH United Kingdom to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 30 November 2021
30 Nov 2021 AP04 Appointment of Oakwood Corporate Secretary Limited as a secretary on 30 November 2021
30 Nov 2021 AP01 Appointment of David John Grainger as a director on 30 November 2021
05 Nov 2021 TM02 Termination of appointment of the Cambridge Partnership Limited as a secretary on 1 November 2021
24 Oct 2021 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
21 Oct 2021 MR01 Registration of charge 096867380003, created on 4 October 2021
19 Oct 2021 MR01 Registration of charge 096867380002, created on 1 October 2021
15 Oct 2021 MR01 Registration of charge 096867380001, created on 4 October 2021
30 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
11 Aug 2021 CS01 Confirmation statement made on 14 July 2021 with updates
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change and Shareholder information change) was registered on 08/07/22
15 Apr 2021 AA01 Previous accounting period extended from 31 July 2020 to 31 December 2020
23 Feb 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
23 Feb 2021 MA Memorandum and Articles of Association
23 Feb 2021 MA Memorandum and Articles of Association
23 Feb 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
12 Feb 2021 SH03 Purchase of own shares.
11 Feb 2021 PSC02 Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021